CN102247562A - 一种治疗痤疮的中药配方 - Google Patents
一种治疗痤疮的中药配方 Download PDFInfo
- Publication number
- CN102247562A CN102247562A CN2011102319380A CN201110231938A CN102247562A CN 102247562 A CN102247562 A CN 102247562A CN 2011102319380 A CN2011102319380 A CN 2011102319380A CN 201110231938 A CN201110231938 A CN 201110231938A CN 102247562 A CN102247562 A CN 102247562A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicinal
- root
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 23
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 21
- 239000003814 drug Substances 0.000 claims description 26
- 238000002360 preparation method Methods 0.000 claims description 22
- 241000628997 Flos Species 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 8
- 229940023488 pill Drugs 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- -1 electuary Substances 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 239000006189 buccal tablet Substances 0.000 claims description 2
- 229940046011 buccal tablet Drugs 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 9
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000028327 secretion Effects 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 206010014080 Ecchymosis Diseases 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 239000005556 hormone Substances 0.000 abstract description 2
- 229940088597 hormone Drugs 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 210000002374 sebum Anatomy 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 244000061508 Eriobotrya japonica Species 0.000 abstract 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000009022 Smilax rotundifolia Species 0.000 abstract 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 abstract 1
- 244000299492 Thespesia populnea Species 0.000 abstract 1
- 235000009430 Thespesia populnea Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 206010007247 Carbuncle Diseases 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 238000001035 drying Methods 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- YFVGIJBUXMQFOF-PJOVQGMDSA-N 5-hydroxy-2-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 YFVGIJBUXMQFOF-PJOVQGMDSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- RKWHWFONKJEUEF-GQUPQBGVSA-O Cyanidin 3-O-glucoside Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 RKWHWFONKJEUEF-GQUPQBGVSA-O 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- YFVGIJBUXMQFOF-SAXLCNSLSA-N Linarin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4ccc(OC)cc4)Oc3c2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 YFVGIJBUXMQFOF-SAXLCNSLSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000032696 parturition Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- DSNIKOZTDZBWKD-XMNJDQQWSA-N yejuhua lactone Chemical compound O([C@H]1C2C[C@H]([C@@](C3C1C(=CC3)C)(C)O)OC(=O)C)C(=O)C2(C1(C)C=C2)CC22C1[C@H]1OC(=O)C(=C)C1CC[C@@]2(C)O DSNIKOZTDZBWKD-XMNJDQQWSA-N 0.000 description 2
- JRHJXXLCNATYLS-SOOLLQOPSA-N (2s,6s,7ar)-2-[(2e,4e,6e,8e,10e,12e,14e,16e)-17-[(1r,4r)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-6,11,15-trimethylheptadeca-2,4,6,8,10,12,14,16-octaen-2-yl]-4,4,7a-trimethyl-2,5,6,7-tetrahydro-1-benzofuran-6-ol Chemical compound C/C([C@@H]1C=C2C(C)(C)C[C@H](O)C[C@@]2(C)O1)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C JRHJXXLCNATYLS-SOOLLQOPSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- IFYMEZNJCAQUME-APKWKYNESA-N Chrysanthemaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C IFYMEZNJCAQUME-APKWKYNESA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- OPQCAZJRIRHZQK-UHFFFAOYSA-N Eucarvone Natural products CC1=CC=CCC(C)(C)C1=O OPQCAZJRIRHZQK-UHFFFAOYSA-N 0.000 description 1
- QNGQIURXCUHNAT-UHFFFAOYSA-N Eucarvone Chemical compound CC1=CC=CC(C)(C)CC1=O QNGQIURXCUHNAT-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 235000007421 Mentha citrata Nutrition 0.000 description 1
- 244000007703 Mentha citrata Species 0.000 description 1
- 235000008660 Mentha x piperita subsp citrata Nutrition 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- GJYJYFHBOBUTBY-UHFFFAOYSA-N alpha-camphorene Chemical compound CC(C)=CCCC(=C)C1CCC(CCC=C(C)C)=CC1 GJYJYFHBOBUTBY-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940029329 intrinsic factor Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000000590 parasiticidal effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种治疗痤疮的中药配方,以重量份计,包括以下成分:黄芩8-12;黄连8-12;苦参8-12;桑白皮8-12;枇杷叶8-12;生地各8-12;蚤休8-12;丹皮10-14;土茯苓25-35;赤芍7-11;连翘12-18;野菊花15-21;甘草4-8;黄柏4-8。本发明的治疗痤疮的中药配方兼具滋阴补肾、活血化瘀、清热排毒作用,多种中药成分相辅相成,凉血消斑、清利三焦、疏风散热。调节机体内分泌,维持体内激素平衡、促进皮脂代谢、抑制细菌生长。治疗效果显著,无毒副作用。
Description
技术领域
本发明涉及一种治疗痤疮的中药配方。
背景技术
痤疮俗称“青春痘”,又叫“面疱”、“粉刺”、“酒刺”、“暗疮”等,是由于毛囊及皮脂腺阻塞,发炎所引发的一种慢性炎症性皮肤病。痤疮发生的因素多种多样,但最直接的因素就是毛孔堵塞。毛孔堵塞以后,毛囊里面的油脂排不出来,越积越多就形成一个个小痘痘。
西医认为,痤疮产生的内因是内分泌功能失调,雄性激素分泌增多或相对增高,刺激皮脂腺肥大增生,分泌油脂量增多。直接诱发的外因包括神经精神因素、饮食因素、药物因素、化妆品及皮肤护理因素等。
中医认为面鼻及胸背部属肺,本病常由肺经风热阻于肌肤所致;或因过食肥甘、油腻、辛辣食物,脾胃蕴热,湿热内生,熏蒸于面而成;或因青春之体,血气方刚,阳热上升,与风寒相搏,郁阻肌肤所致。
西医常采用抗生素、性激素、维甲酸类等来治疗痤疮,虽有一定效果,但治表不治里,诱发痤疮的内在因素仍然存在,并且用这些化学药物治疗存在一定的副作用。
发明内容
针对上述现有技术存在的问题,本发明的目的是提供一种治疗痤疮的中药配方,其为存中药制剂,治疗效果显著,无毒无副作用。
为了解决上述问题,本发明采用以下技术方案:
一种治疗痤疮的中药配方,以重量份计,包括以下成分:黄芩8-12;黄连8-12;苦参8-12;桑白皮8-12;枇杷叶8-12;生地各8-12;蚤休8-12;丹皮10-14;土茯苓25-35;赤芍7-11;连翘12-18;野菊花15-21;甘草4-8;黄柏4-8。
药理分析:
黄岑:苦,寒。归肺、胆、脾、大肠、小肠经。清热燥湿,泻火解毒,止血,安胎,降血压。用于湿温、暑温胸闷呕恶,湿热痞满,泻痢,黄疸,肺热咳嗽,高热烦渴,血热吐衄,痈肿疮毒,胎动不安。
黄连:苦,寒,无毒。归心、脾、胃、肝、胆、大肠经。清热燥湿,泻火解毒。用于湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疔疮;外治湿疹,湿疮,耳道流脓。
黄柏:苦,寒。归肾、膀胱、大肠经。清热燥湿,泻火解毒,除骨蒸清虚热。用于湿热泻痢,黄疸,带下,热淋,脚气,痿辟,骨蒸劳热,盗汗,遗精,疮疡肿毒,湿疹瘙痒。黄柏煎剂、水浸剂于体外对多种致病性皮肤真菌、阴道滴虫等均有不同程度的抑制作用。
苦参:性寒,有清热燥湿,杀虫的功效,苦参浴能够清除下焦湿热,并且杀虫止痒,对皮肤瘙痒有很好的缓解作用,能够平衡油脂分泌,疏通并收敛毛孔,清除皮肤内毒素杂质,丰富的本草营养,促进受损血管神经细胞的生长和修复,恢复皮下毛细血管细胞活力,肌肤重现紧致细滑,起到美容护肤的作用。《药性论》记:治热毒风,皮肌烦躁生疮,赤癞眉脱,主除大热嗜睡,治腹中冷痛,中恶腹痛,除体闷,治心腹积。
桑白皮:甘寒,入肺经。泻肺平喘,利水消肿。用于肺热咳喘,面目浮肿,小便不利等症。
枇杷叶:苦,微寒。归肺,胃经。有清热、润肺、止咳化痰等功效。枇杷叶的水煎剂或乙酸乙酯提取物对白色或金黄色葡萄球菌、肺炎双球菌、福氏痢疾杆菌均有抗菌作用。
生地:甘,寒。归心、肝、肾经。清热凉血,养阴,生津。用于热病舌绛烦渴,阴虚内热,骨蒸劳热,内热消渴,吐血,衄血,发斑发疹。
丹皮:味苦、辛,微寒。归心、肝、肾经。自汗多者勿用,为能走泄津液也。痘疹初起勿用,为其性专散血牡丹皮-中药材,不无根脚散阔之虑(《本经逢原》)。另具有抗炎、抑菌的作用。
土茯苓:甘淡,平。归肝经、胃经、脾经。解毒,除湿,利关节. 土茯苓-原植物主治:治梅毒,淋浊,筋骨挛痛,脚气,疔疗疮,痈肿,瘰疬。健脾胃,强筋骨,去风湿,利关节,止泄泻。治拘挛骨痛;恶疮痈肿。解汞粉、银朱毒(《纲目》)。疔痈肿、喉痹,除周身寒湿、恶疮(《本草正》)。
赤芍:味苦,性微寒。归肝经。具有清热凉血、散瘀止痛的功能。生赤芍以清热凉血力胜。多用于温病热入血分的身热出血,目赤肿痛,痈肿疮毒。泻脾火,降气,行血,破瘀,散血块,止腹痛,退血热,攻痈疮,治疥癞(《滇南本草》)。
连翘:苦,微寒。入心、肺、小肠经。主寒热,鼠痿,瘰疬,痈肿恶疮,瘿瘤,结热(《本经》)。另具抗炎、抗病原菌和解热的作用。
野菊花:性微寒,味苦、辛。全草含多种挥发油,包括樟烯(Camphorene)、樟脑(Camphor)、葛缕酮(Carvone)、柠檬烯 野菊花(Limonene)等,也含有蒙花甙(Linarin)、木犀草素甙,矢车菊甙(Chrysanthemin)、菊黄质、多糖、香豆精类、野菊花内酯(Yejuhua Lactone)等。清热解毒,消肿。疔疮;痈疽;丹毒;湿疹;皮炎;风热感冒;咽喉肿痛;高血压病。对金黄色葡萄球菌、白喉杆菌、链球菌、绿脓杆菌、蒺疾杆菌、流感病毒,均有抑制作用。
蚤休:味苦,微寒。入心、肝经。消诸疮,无名肿毒,利小便(《滇南本草》)。
甘草:性平,味甘,归十二经。有解毒、祛痰、止痛、解痉以至抗癌等药理作用,用于痈疽疮疡、咽喉肿痛等。
本发明的中药配方可以采用片剂、颗粒剂、丸剂、胶囊剂、溶液剂、口服液、口含片、颗粒剂、冲剂、散剂、混悬剂、粉剂等剂型,优选地,可以采用溶液剂、片剂、颗粒剂和丸剂。
使用效果: 治疗组:选受试者50例,其中25例男性,25例女性,年龄15-30岁,早晚两次服用本发明的中药配方,持续1个月。 对照组:选受试者50例,其中25例男性,25例女性,年龄15-30岁,用口服四环素,外用维甲酸霜剂,进行治疗,持续1个月。
评判标准:皮肤症状消失,无异常为治愈;痤疮明显减少,皮损消退50%以上为有效;症状无缓和或皮损基本无消退为无效。
持续治疗1个疗程后,结果显示,治疗组中治愈人数40人;有效人数9人;无效人数1人,总体有效率达98%。而对照组中治愈人数15人;有效人数26人;无效人数9人;总体有效率为82%。
本发明的治疗痤疮的中药配方兼具滋阴补肾、活血化瘀、清热排毒作用,多种中药成分相辅相成,凉血消斑、清利三焦、疏风散热。调节机体内分泌,维持体内激素平衡、促进皮脂代谢、抑制细菌生长。治疗效果显著,无毒副作用。
具体实施方式
为了更好地理解本发明,下面通过实施例来描述本发明。
实施例1
一种治疗痤疮的中药配方,以重量份计,包括以下成分:
黄芩8;
黄连8;
苦参8;
桑白皮8;
枇杷叶8;
生地各8;
蚤休8;
丹皮10;
土茯苓25;
赤芍7;
连翘12;
野菊花15;
甘草4;和
黄柏4。
其制备方法如下:
取黄芩8、黄连8、苦参8、桑白皮8、枇杷叶8、生地各8、蚤休8、丹皮10、土茯苓25、赤芍7、连翘12、野菊花15、甘草4、黄柏4;
将上述中药洗净,去杂质,放入容器加水没过药材浸泡,30分钟后,大火煎煮至沸腾,然后文火慢熬1小时;
将药汁滤出,分袋包装,一袋200ml,早晚各服一袋,1个月为一疗程。
实施例2:
一种治疗痤疮的中药配方,以重量份计,包括以下成分:
黄芩8;
黄连8;
苦参8;
桑白皮8;
枇杷叶8;
生地各8;
蚤休8;
丹皮10;
土茯苓25;
赤芍7;
连翘12;
野菊花15;
甘草4;和
黄柏4。
其制备方法如下:
取黄芩8、黄连8、苦参8、桑白皮8、枇杷叶8、生地各8、蚤休8、丹皮10、土茯苓25、赤芍7、连翘12、野菊花15、甘草4、黄柏4;
洗净,干燥,将上述药材混合,每公斤加入大约10L水,文火煎0.5-1小时,大火煎1-2小时;
取煎液过150目筛,后用浓缩器浓缩至相对密度1.10-1.20的清膏,取2/3清膏在120℃下喷雾干燥,得清膏粉末,将粉末与剩余1/3清膏混合,制粒;颗粒分装机分装,即得颗粒剂。
实施例3
一种治疗痤疮的中药配方,以重量份计,包括以下成分:
黄芩12;
黄连12;
苦参12;
桑白皮12;
枇杷叶12;
生地各12;
蚤休12;
丹皮14;
土茯苓35;
赤芍11;
连翘18;
野菊花21;
甘草8;和
黄柏8。
其制备方法如下:
取黄芩12、黄连12、苦参12、桑白皮12、枇杷叶12、生地各12、蚤休12、丹皮14、土茯苓35、赤芍11、连翘18、野菊花21、甘草8、黄柏8;
洗净,干燥,将上述药材混合,每公斤加入大约10L水,文火煎0.5-1小时,大火煎1-2小时;取煎液过150目筛,后用浓缩器浓缩至相对密度1.10-1.20的清膏,取2/3清膏在120℃下喷雾干燥,得清膏粉末,将粉末与剩余1/3清膏混合,制粒;加入适当辅剂硬脂酸镁,压片机压片,包衣,即得片剂。
实施例4
一种治疗痤疮的中药配方,以重量份计,包括以下成分:
黄芩10;
黄连10;
苦参10;
桑白皮10;
枇杷叶10;
生地各10;
蚤休10;
丹皮12;
土茯苓30;
赤芍9;
连翘15;
野菊花18;
甘草6;和
黄柏6。
其制备方法如下:
取黄芩10、黄连10、苦参10、桑白皮10、枇杷叶10、生地各10、蚤休10、丹皮12、土茯苓30、赤芍9、连翘15、野菊花18、甘草6、黄柏6;
洗净,干燥,将上述药材混合,用粉碎机粉碎为150-180目细粉,加入适当蜂蜜混合,制丸机制丸,低温干燥,分装,即得丸剂。
Claims (4)
1.一种治疗痤疮的中药配方,其特征在于,以重量份计,包括以下成分:黄芩8-12;黄连8-12;苦参8-12;桑白皮8-12;枇杷叶8-12;生地各8-12;蚤休8-12;丹皮10-14;土茯苓25-35;赤芍7-11;连翘12-18;野菊花15-21;甘草4-8;黄柏4-8。
2.一种治疗痤疮的中药配方,其特征在于,以重量份计,优选包括以下成分:黄芩10;黄连10;苦参10;桑白皮10;枇杷叶10;生地各10;蚤休10;丹皮12;土茯苓30;赤芍9;连翘15;野菊花18;甘草6;黄柏6。
3.根据权利要求1所述的中药配方,其特征在于,所述中药配方采用片剂、颗粒剂、丸剂、胶囊剂、溶液剂、口服液、口含片、颗粒剂、冲剂、散剂、混悬剂、粉剂。
4.根据权利要求3所述的中药配方,其特征在于,所述中药配方采用溶液剂、片剂、颗粒剂和丸剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102319380A CN102247562A (zh) | 2011-08-15 | 2011-08-15 | 一种治疗痤疮的中药配方 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102319380A CN102247562A (zh) | 2011-08-15 | 2011-08-15 | 一种治疗痤疮的中药配方 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102247562A true CN102247562A (zh) | 2011-11-23 |
Family
ID=44975366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011102319380A Pending CN102247562A (zh) | 2011-08-15 | 2011-08-15 | 一种治疗痤疮的中药配方 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102247562A (zh) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102370759A (zh) * | 2011-11-17 | 2012-03-14 | 中国中医科学院中医临床基础医学研究所 | 一种治疗痤疮的中药复方制剂及其制备方法 |
| CN103333753A (zh) * | 2013-07-19 | 2013-10-02 | 苏州市天灵中药饮片有限公司 | 中草药洁面皂及其制备方法 |
| CN104434620A (zh) * | 2014-10-13 | 2015-03-25 | 金日制药(中国)有限公司 | 一种祛痘组合物及其制备方法 |
| CN105031159A (zh) * | 2015-06-19 | 2015-11-11 | 上海贝泰妮生物科技有限公司 | 一种具有祛痘功效的中药提取物制剂及其制备方法 |
| CN105079623A (zh) * | 2015-09-21 | 2015-11-25 | 成都艾比科生物科技有限公司 | 一种用于治疗青春痘的中药组合物 |
| CN105343472A (zh) * | 2015-11-30 | 2016-02-24 | 陈本钦 | 一种治疗肺经蕴热痤疮的中药组合物 |
| CN102370759B (zh) * | 2011-11-17 | 2016-12-14 | 中国中医科学院中医临床基础医学研究所 | 一种治疗痤疮的中药复方制剂及其制备方法 |
| CN108671087A (zh) * | 2018-06-28 | 2018-10-19 | 成都中医药大学附属医院 | 一种治疗酒渣鼻的药物组合物及其制备方法和用途 |
-
2011
- 2011-08-15 CN CN2011102319380A patent/CN102247562A/zh active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102370759A (zh) * | 2011-11-17 | 2012-03-14 | 中国中医科学院中医临床基础医学研究所 | 一种治疗痤疮的中药复方制剂及其制备方法 |
| CN102370759B (zh) * | 2011-11-17 | 2016-12-14 | 中国中医科学院中医临床基础医学研究所 | 一种治疗痤疮的中药复方制剂及其制备方法 |
| CN103333753A (zh) * | 2013-07-19 | 2013-10-02 | 苏州市天灵中药饮片有限公司 | 中草药洁面皂及其制备方法 |
| CN103333753B (zh) * | 2013-07-19 | 2014-12-17 | 苏州市天灵中药饮片有限公司 | 中草药洁面皂及其制备方法 |
| CN104434620A (zh) * | 2014-10-13 | 2015-03-25 | 金日制药(中国)有限公司 | 一种祛痘组合物及其制备方法 |
| CN105031159A (zh) * | 2015-06-19 | 2015-11-11 | 上海贝泰妮生物科技有限公司 | 一种具有祛痘功效的中药提取物制剂及其制备方法 |
| CN105079623A (zh) * | 2015-09-21 | 2015-11-25 | 成都艾比科生物科技有限公司 | 一种用于治疗青春痘的中药组合物 |
| CN105343472A (zh) * | 2015-11-30 | 2016-02-24 | 陈本钦 | 一种治疗肺经蕴热痤疮的中药组合物 |
| CN108671087A (zh) * | 2018-06-28 | 2018-10-19 | 成都中医药大学附属医院 | 一种治疗酒渣鼻的药物组合物及其制备方法和用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104338083A (zh) | 一种治疗月经不调的药物及其制备方法 | |
| CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN101422579B (zh) | 一种治疗口腔溃疡的中药制剂 | |
| CN102247562A (zh) | 一种治疗痤疮的中药配方 | |
| CN103893738B (zh) | 一种抑制肿瘤生长中药组合物及其制备方法 | |
| CN102579813B (zh) | 一种防脱生发内服中药组合物 | |
| CN102068527B (zh) | 一种根除青春痘的药物 | |
| CN105029983A (zh) | 一种乌发美颜的药枕 | |
| CN101164600A (zh) | 一种治疗痤疮、青春痘的药物 | |
| CN104042673A (zh) | 一种治疗高血压的中药胶囊及其制备方法 | |
| CN102872368B (zh) | 一种用于泻火解毒的中药贴敷制剂 | |
| CN104940886A (zh) | 一种治疗脂溢性脱发的外用制剂及制法 | |
| CN102247473A (zh) | 一种治疗青春痘的中药配方 | |
| CN102274420A (zh) | 一种治疗痤疮的中药组合物 | |
| CN103860787B (zh) | 含有花蛤有效成分的治疗痤疮的外用中药 | |
| CN103610934B (zh) | 一种治疗咽炎的中药 | |
| CN102274338A (zh) | 一种治疗痤疮的中成药 | |
| CN108096506A (zh) | 一种祛疣中药植物提取液及其制备方法 | |
| CN102274435A (zh) | 一种治疗痤疮的中药 | |
| CN105327236A (zh) | 一种用于治疗糖尿病的药物 | |
| CN105521332A (zh) | 治疗肛裂的中药组合物及其制备方法和应用 | |
| CN102274465A (zh) | 治疗痤疮的中药 | |
| CN102274434A (zh) | 一种治疗青春痘的中药 | |
| CN102274436A (zh) | 一种治疗青春痘的中药组合物 | |
| CN108114220A (zh) | 一种治疗鼻炎的胶囊剂药物及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111123 |